Adaptimmune Therapeutics Plc (ADAPY)
0.025
-0.01
(-19.09%)
USD |
OTCM |
Jan 13, 16:00
Adaptimmune Therapeutics Gross Profit (Quarterly): 8.770M for June 30, 2025
Gross Profit (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | -10.79M |
| Evaxion AS | 0.00 |
| NuCana Plc | -0.093M |
| Mereo BioPharma Group Plc | 0.00 |